Denali Therapeutics (DNLI) Current Leases (2019 - 2025)
Denali Therapeutics (DNLI) reported Current Leases of $9.2 million for Q3 2025, up 14.04% year-over-year from $8.0 million in Q3 2024, and up 3.3% quarter-over-quarter from $8.9 million in Q2 2025.
Denali Therapeutics (DNLI) Current Leases (2019 - 2025) Analysis & Trends
Denali Therapeutics (DNLI) has 7 years of Current Leases data on file, last reported at $9.2 million in Q3 2025.
- Current Leases for Q3 2025 came in at $9.2 million, up 14.04% year-over-year; the trailing twelve-month figure through Sep 2025 was $9.2 million (up 14.04% YoY), and the FY2024 annual result was $8.3 million, up 14.44% from the prior year.
- Current Leases improved to $9.2 million in Q3 2025 per DNLI's latest filing, from $8.9 million in the prior quarter.
- Over five years, Current Leases peaked at $9.2 million in Q3 2025 and troughed at $4.9 million in Q1 2021.
- A 5-year average of $7.0 million and a median of $7.1 million in 2022 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2023: Current Leases soared 34.58% in 2022, then retreated 0.79% in 2023.
- A 5-year view of Current Leases shows it stood at $5.5 million in 2021, then soared by 34.2% to $7.3 million in 2022, then slipped by 0.79% to $7.3 million in 2023, then climbed by 14.44% to $8.3 million in 2024, then advanced by 10.3% to $9.2 million in 2025.
- Business Quant data shows DNLI's Current Leases at $9.2 million in Q3 2025, $8.9 million in Q2 2025, and $8.6 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Denali Therapeutics | 4.35 Bn | 4.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9.16 Mn |
| Jun 30, 2025 | 8.87 Mn |
| Mar 31, 2025 | 8.59 Mn |
| Dec 31, 2024 | 8.31 Mn |
| Sep 30, 2024 | 8.04 Mn |
| Jun 30, 2024 | 7.77 Mn |
| Mar 31, 2024 | 7.51 Mn |
| Dec 31, 2023 | 7.26 Mn |
| Sep 30, 2023 | 7.01 Mn |
| Jun 30, 2023 | 6.77 Mn |
| Mar 31, 2023 | 6.54 Mn |
| Dec 31, 2022 | 7.32 Mn |
| Sep 30, 2022 | 7.07 Mn |
| Jun 30, 2022 | 5.87 Mn |
| Mar 31, 2022 | 5.66 Mn |
| Dec 31, 2021 | 5.45 Mn |
| Sep 30, 2021 | 5.25 Mn |
| Jun 30, 2021 | 5.06 Mn |
| Mar 31, 2021 | 4.88 Mn |
| Dec 31, 2020 | 4.69 Mn |